EA200700573A2 - Применение антиатеротромботического соединения при получении лекарственных средств, предназначенных для лечения сосудистых нарушений - Google Patents

Применение антиатеротромботического соединения при получении лекарственных средств, предназначенных для лечения сосудистых нарушений

Info

Publication number
EA200700573A2
EA200700573A2 EA200700573A EA200700573A EA200700573A2 EA 200700573 A2 EA200700573 A2 EA 200700573A2 EA 200700573 A EA200700573 A EA 200700573A EA 200700573 A EA200700573 A EA 200700573A EA 200700573 A2 EA200700573 A2 EA 200700573A2
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
aterothrombotic
medicines
obtaining
intended
Prior art date
Application number
EA200700573A
Other languages
English (en)
Other versions
EA013874B1 (ru
EA200700573A3 (ru
Inventor
Мари-Доминик Фратаччи
Аньес Де-Кордуе
Лоранс Лерон
Тони Верберен
Ален Рюпен
Жильбер Лавьелль
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200700573A2 publication Critical patent/EA200700573A2/ru
Publication of EA200700573A3 publication Critical patent/EA200700573A3/ru
Publication of EA013874B1 publication Critical patent/EA013874B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Настоящее изобретение касается применения специфичного антагониста ТП рецепторов для получения лекарственных средств, предназначенных для лечения сосудистых нарушений у пациентов, имеющих в анамнезе цереброваскулярный криз (CVA), особенно для снижения случаев церебрально-васкулярных и сердечно-сосудистых нарушений у пациентов, анамнез которых включает церебральный ишемический криз (CIA) или транзиторную ишемическую атаку (TIA).
EA200700573A 2006-04-07 2007-04-06 Применение антиатеротромботического соединения для получения лекарственных средств, предназначенных для лечения сосудистых нарушений EA013874B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0603082A FR2899473B1 (fr) 2006-04-07 2006-04-07 Utilisation d'un compose anti-atherothrombotique pour l'obtention de medicaments destines au traitement des troubles vasculaires

Publications (3)

Publication Number Publication Date
EA200700573A2 true EA200700573A2 (ru) 2007-10-26
EA200700573A3 EA200700573A3 (ru) 2007-12-28
EA013874B1 EA013874B1 (ru) 2010-08-30

Family

ID=37084627

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200700573A EA013874B1 (ru) 2006-04-07 2007-04-06 Применение антиатеротромботического соединения для получения лекарственных средств, предназначенных для лечения сосудистых нарушений

Country Status (40)

Country Link
US (1) US20070238785A1 (ru)
EP (2) EP1842537B1 (ru)
JP (1) JP2009532447A (ru)
KR (2) KR20070100658A (ru)
CN (2) CN101693025A (ru)
AP (1) AP2007003952A0 (ru)
AR (1) AR060288A1 (ru)
AT (1) ATE452633T1 (ru)
AU (1) AU2007201525A1 (ru)
BR (1) BRPI0701597A (ru)
CA (1) CA2582394A1 (ru)
CO (1) CO5820217A1 (ru)
CR (1) CR9020A (ru)
CY (1) CY1109793T1 (ru)
DE (1) DE602007003880D1 (ru)
DK (1) DK1842537T3 (ru)
EA (1) EA013874B1 (ru)
ES (1) ES2338600T3 (ru)
FR (1) FR2899473B1 (ru)
GE (1) GEP20094782B (ru)
GT (1) GT200700029A (ru)
HR (1) HRP20100091T1 (ru)
IL (1) IL182406A0 (ru)
MA (1) MA28988B1 (ru)
MX (1) MX2007004108A (ru)
NI (1) NI200700083A (ru)
NO (1) NO20071833L (ru)
NZ (1) NZ554348A (ru)
PE (1) PE20071147A1 (ru)
PL (1) PL1842537T3 (ru)
PT (1) PT1842537E (ru)
RS (1) RS51207B (ru)
SG (1) SG136882A1 (ru)
SI (1) SI1842537T1 (ru)
SV (1) SV2008003053A (ru)
TN (1) TNSN07117A1 (ru)
TW (1) TW200808306A (ru)
UY (1) UY30263A1 (ru)
WO (1) WO2007116138A1 (ru)
ZA (1) ZA200702866B (ru)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102862D0 (en) * 1991-02-11 1991-03-27 Erba Carlo Spa N-imidazolyl derivatives of substituted or alkoxymino tetrahydronaphthalenes and chromans
RU2120292C1 (ru) * 1992-07-22 1998-10-20 Российско-германское акционерное общество закрытого типа "УТИЛЕКС" Способ лечения мозговых сосудистых кризов
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
DE4343776A1 (de) * 1993-12-17 1995-06-22 Schering Ag Cyclopentanonderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
JPH08119936A (ja) * 1994-10-18 1996-05-14 Fujisawa Pharmaceut Co Ltd 複素環式誘導体
FR2805261A1 (fr) * 2000-02-18 2001-08-24 Adir Nouveaux derives d'acides 6-amino ou 6-hydrazinosulfonyl-3- quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2857593B1 (fr) * 2003-07-18 2005-10-14 Servier Lab Composition pharmaceutique orodispersible d'un compose antithrombotique
FR2860436B1 (fr) * 2003-10-03 2006-01-20 Servier Lab Nouvelle association d'un anti-atherothrombotique et d'un antiagregant plaquettaire

Also Published As

Publication number Publication date
KR20090086500A (ko) 2009-08-13
CO5820217A1 (es) 2007-11-30
GT200700029A (es) 2007-10-31
NZ554348A (en) 2008-09-26
JP2009532447A (ja) 2009-09-10
PT1842537E (pt) 2010-01-15
SV2008003053A (es) 2009-12-02
CR9020A (es) 2008-09-23
DE602007003880D1 (de) 2010-02-04
SI1842537T1 (sl) 2010-03-31
SG136882A1 (en) 2007-11-29
EA013874B1 (ru) 2010-08-30
AP2007003952A0 (en) 2007-04-30
ES2338600T3 (es) 2010-05-10
HRP20100091T1 (hr) 2010-04-30
PL1842537T3 (pl) 2010-06-30
WO2007116138A1 (fr) 2007-10-18
BRPI0701597A (pt) 2007-12-11
EP2105132A1 (fr) 2009-09-30
KR20070100658A (ko) 2007-10-11
ATE452633T1 (de) 2010-01-15
NI200700083A (es) 2008-06-09
AU2007201525A1 (en) 2007-10-25
US20070238785A1 (en) 2007-10-11
RS51207B (sr) 2010-12-31
TW200808306A (en) 2008-02-16
CN101049292A (zh) 2007-10-10
EP1842537A1 (fr) 2007-10-10
IL182406A0 (en) 2008-01-20
DK1842537T3 (da) 2010-04-12
GEP20094782B (en) 2009-09-25
TNSN07117A1 (fr) 2008-06-02
CY1109793T1 (el) 2014-09-10
EA200700573A3 (ru) 2007-12-28
NO20071833L (no) 2007-10-08
FR2899473A1 (fr) 2007-10-12
ZA200702866B (en) 2008-07-30
UY30263A1 (es) 2007-05-31
CN101693025A (zh) 2010-04-14
MA28988B1 (fr) 2007-11-01
MX2007004108A (es) 2009-02-16
EP1842537B1 (fr) 2009-12-23
PE20071147A1 (es) 2007-12-22
FR2899473B1 (fr) 2008-06-13
AR060288A1 (es) 2008-06-04
CA2582394A1 (fr) 2007-10-07

Similar Documents

Publication Publication Date Title
MX2010008359A (es) Variantes de alfa-amilasa ts23 con propiedades alteradas.
EA201200793A1 (ru) Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
EA200802184A1 (ru) Фармацевтические композиции с ингибиторами dpp iv
GT200800250A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
EA201001402A1 (ru) Фармацевтические растворы, способ получения и терапевтическое применение
EA201101117A1 (ru) Ингибиторы дпп-4 для лечения диабета у детей
NO20074943L (no) Roflumilast for behandlingen av diabetes mellitus
HUP0800434A2 (en) Template to determine the places of the injections, especially for regular medicament injection and/or blood testing
ATE489371T1 (de) Benzamidglucokinaseaktivatoren
EE05536B1 (et) N-karbamoüülmetüül-4-(R)-fenüül-2-pürrolidinoon, selle valmistamise meetod ja farmatseutiline kasutamine
JP2014501492A5 (ru)
EA200970533A1 (ru) Жидкие композиции антител против бешенства
BRPI0606081A (pt) método e sistema para impor restrições sobre sessões
UA107684C2 (xx) АГОНІСТИ РЕЦЕПТОРА mGlu2
CO6531459A2 (es) Uso de 4-[etil(dimetil)amonio] butanoato en el tratamiento de enfermedades cardiovasculares
WO2011067711A3 (en) Novel heparanase splice variant
EA200700573A2 (ru) Применение антиатеротромботического соединения при получении лекарственных средств, предназначенных для лечения сосудистых нарушений
CR11735A (es) Asociacion de la dronedarona con al menos un diuretico, su aplicacion en terapeutica
WO2008106115A3 (en) Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy
EA201590782A1 (ru) Оксирановые амины
BRPI0811850A2 (pt) Composição concentrada de esmolol, composição pronta para uso, e, método de dosagem de um paciente com uma composição de esmolol.
RS53014B (en) 4R, 5S-ENANTIOMER 2- (5-METHYL-2-OXO-4-PHENYL-PYROLIDIN-1-IL) -ACETAMIDE WITH NOOTROPIC ACTIVITY
FR2974364B1 (fr) Nouveaux derives amino-pyrroliniques, leur utilisation dans la prevention et/ou le traitement du syndrome metabolique
Francis et al. Don’t Call Them Lobbyists
Imamura et al. The study on the anchor point speciation about the legibility of normal and low vision condition in the nursing home

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU